Fonte: Pediatric Neurosurgery. Unidade: FM
Assuntos: DOENÇAS DO SISTEMA NERVOSO, MORFINA (TEREAPIA), ESTIMULAÇÃO CEREBRAL, MANIFESTAÇÕES NEUROLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPEZ, William Omar Contreras et al. Intrathecal Morphine Therapy in the Management of Status Dystonicus in Neurodegeneration Brain Iron Accumulation Type 1. Pediatric Neurosurgery, v. 50, n. 2, p. 94-98, 2014Tradução . . Disponível em: https://doi.org/10.1159/000370005. Acesso em: 30 jul. 2024.APA
Lopez, W. O. C., Schroeder, H. K., Neville, I. S., Teixeira, M. J., Barbosa, D. C., Mônaco, B. A. de, & Fonoff, E. T. (2014). Intrathecal Morphine Therapy in the Management of Status Dystonicus in Neurodegeneration Brain Iron Accumulation Type 1. Pediatric Neurosurgery, 50( 2), 94-98. doi:10.1159/000370005NLM
Lopez WOC, Schroeder HK, Neville IS, Teixeira MJ, Barbosa DC, Mônaco BA de, Fonoff ET. Intrathecal Morphine Therapy in the Management of Status Dystonicus in Neurodegeneration Brain Iron Accumulation Type 1 [Internet]. Pediatric Neurosurgery. 2014 ; 50( 2): 94-98.[citado 2024 jul. 30 ] Available from: https://doi.org/10.1159/000370005Vancouver
Lopez WOC, Schroeder HK, Neville IS, Teixeira MJ, Barbosa DC, Mônaco BA de, Fonoff ET. Intrathecal Morphine Therapy in the Management of Status Dystonicus in Neurodegeneration Brain Iron Accumulation Type 1 [Internet]. Pediatric Neurosurgery. 2014 ; 50( 2): 94-98.[citado 2024 jul. 30 ] Available from: https://doi.org/10.1159/000370005
